Firefly Neuroscience (AIFF) Non-Current Debt (2020 - 2021)
Firefly Neuroscience (AIFF) posted Non-Current Debt of $1.2 million for Q3 2021, down 21.0% on a QoQ basis from $1.5 million in Q2 2021, and up 190.22% year-over-year from $412843.0 in Q3 2020.
Powered by 
Analysis
Firefly Neuroscience (AIFF) Non-Current Debt (2020 - 2021) Analysis & Trends
Firefly Neuroscience has reported Non-Current Debt for 2 years, with the latest figure at $1.2 million in Q3 2021.
- On a quarterly basis, Non-Current Debt rose 190.22% year-over-year to $1.2 million in Q3 2021; TTM through Sep 2021 was $1.2 million, a 190.22% increase from a year earlier, with the FY2020 full-year figure at $450000.0, changed N/A from the prior year.
- Non-Current Debt was $1.2 million for Q3 2021 at Firefly Neuroscience, down from $1.5 million in the prior quarter.
- The five-year high for Non-Current Debt was $1.5 million in Q2 2021, with the low at $300998.0 in Q2 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 31.10 Bn | 29.22 Bn | 2.18 Bn | 10.09 Bn |
| 2 | Lantheus Holdings | 6.59 Bn | 6.00 Bn | 241.86 Mn | 570.35 Mn |
| 3 | Heartflow | 4.24 Bn | 3.87 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.58 Bn | 2.39 Bn | 107.80 Mn | 793.70 Mn |
| 5 | Butterfly Network | 1.75 Bn | 1.62 Bn | 23.29 Mn | - |
| 6 | QuidelOrtho | 954.15 Mn | 830.75 Mn | - | 2.54 Bn |
| 7 | Ceribell | 944.88 Mn | 815.62 Mn | 25.94 Mn | 19.98 Mn |
| 8 | Anbio Biotechnology | 941.05 Mn | 929.15 Mn | - | - |
| 9 | Varex Imaging | 780.16 Mn | 694.86 Mn | 76.70 Mn | 347.10 Mn |
| 10 | Firefly Neuroscience | 23.25 Mn | 14.03 Mn | 253,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2021 | 1.20 Mn |
| Jun 30, 2021 | 1.52 Mn |
| Mar 31, 2021 | 300,999.00 |
| Dec 31, 2020 | 450,000.00 |
| Sep 30, 2020 | 412,843.00 |
| Jun 30, 2020 | 300,998.00 |